相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Assessing multiparametric drug response in tissue engineered tumor microenvironment models
Alexandra R. Harris et al.
METHODS (2018)
Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4
Lisa D. Volk-Draper et al.
PLOS ONE (2017)
A robust in vitro model for trans-lymphatic endothelial migration
Yanbao Xiong et al.
SCIENTIFIC REPORTS (2017)
TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3/-Catenin Pathway upon LPS Stimulation
Jun Li et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2017)
Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
Svetlana Skolekova et al.
CELL COMMUNICATION AND SIGNALING (2016)
Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms
Kathryn M. Kingsmore et al.
INTEGRATIVE BIOLOGY (2016)
Regulation of vascular endothelial growth factor-C by tumor necrosis factor- in the conjunctiva and pterygium
Yoko Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Bruce A. Corliss et al.
MICROCIRCULATION (2016)
Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
Dror Alishekevitz et al.
CELL REPORTS (2016)
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1
Kaoru Fujisaki et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
The Role of TLR4 in Chemotherapy-Driven Metastasis
Sophia Ran
CANCER RESEARCH (2015)
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
Shih-Wei Wang et al.
CARCINOGENESIS (2015)
Th2 Cytokines Inhibit Lymphangiogenesis
Ira L. Savetsky et al.
PLOS ONE (2015)
Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
Lisa Volk-Draper et al.
CANCER RESEARCH (2014)
A systematic review of bevacizumab efficacy in breast cancer
Iben Kumler et al.
CANCER TREATMENT REVIEWS (2014)
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer
M. A. Socinski
CURRENT ONCOLOGY (2014)
Emerging roles of lymphatic endothelium in regulating adaptive immunity
Catherine M. Card et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci et al.
MEDIATORS OF INFLAMMATION (2014)
Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
Kosuke Watari et al.
PLOS ONE (2014)
Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis
Huan Yang et al.
PLOS ONE (2014)
TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling
Hong Ji et al.
NATURE COMMUNICATIONS (2014)
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Justin M. Balko et al.
CANCER DISCOVERY (2014)
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Steven A. Stacker et al.
NATURE REVIEWS CANCER (2014)
Interstitial Flow in a 3D Microenvironment Increases Glioma Invasion by a CXCR4-Dependent Mechanism
Jennifer M. Munson et al.
CANCER RESEARCH (2013)
Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis
Ramin Shayan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer: A Review
Carey K. Anders et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer
Fuqiang Yin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Sandeep Rajput et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer
Jianbo Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature
Jun Wang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
OPINION Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Melody A. Swartz et al.
NATURE REVIEWS CANCER (2012)
Tumor Cell Invasion Is Promoted by Interstitial Flow-Induced Matrix Priming by Stromal Fibroblasts
Adrian C. Shieh et al.
CANCER RESEARCH (2011)
Molecular mechanisms of lymphangiogenesis in development and cancer
Imke Albrecht et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
Rabab A. A. Mohammed et al.
MODERN PATHOLOGY (2011)
CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma
Beatrice Cambien et al.
PLOS ONE (2011)
Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages
Shinae Kang et al.
BLOOD (2009)
Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
M. Szajnik et al.
ONCOGENE (2009)
Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics
Patrizia Sini et al.
CANCER RESEARCH (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling
Jacqueline D. Shields et al.
CANCER CELL (2007)
Chemokine-mediated migration of melanoma cells towards lymphatics - a mechanism contributing to metastasis
J. D. Shields et al.
ONCOGENE (2007)
Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics
Rui-Cheng Ji
CANCER AND METASTASIS REVIEWS (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor
JM Lin et al.
CANCER RESEARCH (2005)
Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Publication with Expression of Concern. See vol. 79, pg. 4305, 2019)
B Huang et al.
CANCER RESEARCH (2005)
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
YL He et al.
CANCER RESEARCH (2005)
The treatment of advanced gastric cancer: New findings on the activity of the taxanes
E Van Cutsem
ONCOLOGIST (2004)
Lymphatic metastasis in the absence of functional intratumor lymphatics
TP Padera et al.
SCIENCE (2002)
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling
YL He et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol™) in murine and human breast cancer cell lines
M Zaks-Zilberman et al.
CYTOKINE (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)